Advertisement
Screener

CURIS, INC. (CRIS) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

1.6 / 5 stars · 32/99 Roast Me

CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.50% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2023-11-02

  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2022-03-31 was 1.40%, a 250.00% increase year-over-year.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2021-03-31 was 0.40%, a 55.56% decline year-over-year.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2020-03-31 was 0.90%, a 64.00% decline year-over-year.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2019-03-31 was 2.50%.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2019 was 1.50%, a 40.00% decline from fiscal 2018.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2018 was 2.50%, a 25.00% increase from fiscal 2017.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2017 was 2.00%, a 42.86% increase from fiscal 2016.
  • CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2016 was 1.40%, a 6.67% decline from fiscal 2015.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month
2023-09-303.50%
10-Q · filed 2023-11-02
2023-06-303.50%
10-Q · filed 2023-08-03
2022-09-301.40%
10-Q · filed 2023-11-02
2022-06-301.40%
10-Q · filed 2023-08-03
2022-03-311.40%
10-Q · filed 2023-05-04
2021-09-300.40%
10-Q · filed 2022-11-09
2021-06-300.40%
10-Q · filed 2022-08-04
2021-03-310.40%
10-Q · filed 2022-05-05
2020-09-300.40%
10-Q · filed 2021-11-09		40.00%
10-Q · filed 2020-11-10
2020-06-300.40%
10-Q · filed 2021-08-03		0.90%
10-Q · filed 2020-08-04
2020-03-310.90%
10-Q · filed 2021-05-12
2019-12-311.50%
10-K · filed 2020-03-19
2019-09-30230.00%
10-Q · filed 2020-11-10		2.30%
10-Q · filed 2019-11-05
2019-06-302.50%
10-Q · filed 2020-08-04		2.30%
10-Q · filed 2019-08-09
2019-03-312.50%
10-Q · filed 2020-05-12
2018-12-312.50%
10-K · filed 2020-03-19
2018-09-302.50%
10-Q · filed 2019-11-05
2018-06-302.50%
10-Q · filed 2019-08-09
2017-12-312.00%
10-K · filed 2019-03-26
2017-09-302.00%
10-Q · filed 2018-11-01
2017-06-302.00%
10-Q · filed 2018-08-02
2016-12-311.40%
10-K · filed 2018-03-08
2016-09-301.40%
10-Q · filed 2017-11-07
2016-06-301.40%
10-Q · filed 2017-08-03
2016-03-311.60%
10-Q · filed 2017-05-04
2015-12-311.50%
10-K · filed 2018-03-08
2015-09-301.50%
10-Q · filed 2016-11-03
2015-06-301.50%
10-Q · filed 2016-08-04
2015-03-311.60%
10-Q · filed 2016-05-09
2014-09-301.85%
10-Q · filed 2015-11-09
2014-06-301.85%
10-Q · filed 2015-08-06
2014-03-311.90%
10-Q · filed 2015-05-07
2013-12-311.00%
10-K · filed 2016-02-29
2012-12-311.00%
10-K · filed 2013-03-13
2012-09-301.00%
10-Q · filed 2012-11-06
2012-06-301.00%
10-Q · filed 2012-08-09
2011-12-311.20%
10-K · filed 2013-03-13
2011-09-301.20%
10-Q · filed 2012-11-06
2011-06-302.40%
10-Q · filed 2012-08-09
2010-12-312.30%
10-K · filed 2013-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Advertisement